H.B. Fuller (FUL) Q1 2026 Earnings Call Transcript

Adjusted EBITDA of $119.0M (+4% YoY) and adjusted EPS of $0.57 (+6% YoY) contrasted with organic revenue down 6.6% YoY (pricing +0.6%, volume -7.2%). Management raised 2026 guidance: net revenue now expected up mid-single digits, organic up low-single digits; adjusted EBITDA $645M–$675M; adjusted EPS $4.55–$4.90. Company announced a minimum 10% global price increase effective April 1 amid over 40 supplier force majeure notices tied to Middle East conflict (broad raw material constraints and spot price spikes), raised Quantum Leap cost-savings to $15M, paused near-term M&A and prioritized share repurchases while targeting 2.5x–3.0x net debt/EBITDA (current 3.1x).

Analysis

H.B. Fuller’s recent playbook — rapid commercial price moves, selective allocation of scarce feedstocks, and a pause on near-term M&A while boosting share repurchases — creates an asymmetric opportunity: they can capture displaced volumes now and convert pricing into durable margin expansion as competitors face raw-material access problems. The durability of that gain will depend on how many of those incremental supply agreements are converted into multi-quarter contracts rather than one‑off spot fills; insistence on longer-term supply commitments will be the difference between a transitory bump and stickier market share.

The principal second‑order effect is on the raw‑material base itself. Systematic underinvestment by commodity suppliers (thin margin environment pre‑conflict) means capacity closures are not easily reversed; even a short conflict will cascade into months of higher structural input prices because replacement capacity and logistics re‑routing take time. This raises a classic roll‑forward volatility trade: firms with superior contracting/sourcing capture both higher price realization and a wider margin wedge, while spot‑dependent rivals will see margin compression and forced inventory builds.

Key risks and time horizons: expect visibility to remain poor on the order book over the next 30–90 days as customers de‑risk inventories, but monitor 3–12 month signals—supplier FMs rescinded, long‑form offtake wins, and working‑capital normalization—that would either validate durable share gains or presage demand destruction. Tail events that would reverse the thesis include rapid diplomatic resolution with immediate freight/commodity normalization (weeks), or deeper demand destruction from sustained end‑market inflation (quarters).

Actionable monitoring items that will move the thesis: cadence of long‑term supply contracts signed with major OEMs (durability), sequential working‑capital trends (cash conversion), VAM and key intermediate spreads (input pass‑through), and pace/size of announced buybacks (capital allocation discipline). These will determine whether the current margin expansion is reversible or a structural re‑rating opportunity.

Key Decisions for Investors

• Long FUL equity (3–12 month): establish a core long position in FUL sized to capture re-rating if management locks incremental volumes into multi‑year supply contracts. Hedge downside with a 3–6 month protective put (or put spread) sized to limit drawdown to the fund’s risk tolerance — reward: upside from margin re‑rating + buybacks; risk: deeper volume loss or raw‑cost spike that overwhelms price.
• Options taper to limit capital outlay (6–12 month): buy a FUL 12‑month call spread (long near‑term call / short higher strike call) to capture upside from sustained price realization while capping premium paid. Use this if outright equity exposure is constrained; payoff tilts positive if pricing survives and working capital stabilizes.
• Pair trade (6–12 month): long FUL / short a spot‑dependent adhesives/chemical peer (select regional specialty or commodity chemical name lacking global contracting capabilities) to isolate sourcing advantage. Target neutral market beta; stop if industry spot spreads compress materially (recovery in feedstock availability), which would remove the arbitrage.
• Event‑driven watchlist & trigger order: place contingent buys or option rollouts keyed to three triggers over the next 90–180 days — (a) two consecutive months of improving organic volumes, (b) announcement of multi‑year customer offtake/MOU, or (c) demonstrable working‑capital stabilization. If any trigger hits, increase longs to full allocation; if none hit within 180 days, reduce exposure and pivot to volatility trades on chemical inputs.